Table of Contents Author Guidelines Submit a Manuscript
International Journal of Cell Biology
Volume 2012, Article ID 516789, 7 pages
http://dx.doi.org/10.1155/2012/516789
Review Article

Integrin Trafficking and Tumor Progression

Department of Cancer and Cell Biology, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA

Received 27 July 2011; Accepted 12 September 2011

Academic Editor: Jun Chung

Copyright © 2012 Sejeong Shin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Jean, P. Gravelle, J. J. Fournie, and G. Laurent, “Influence of stress on extracellular matrix and integrin biology,” Oncogene, vol. 30, no. 24, pp. 2697–2706, 2011. View at Publisher · View at Google Scholar · View at PubMed
  2. C. C. Dufort, M. J. Paszek, and V. M. Weaver, “Balancing forces: architectural control of mechanotransduction,” Nature Reviews Molecular Cell Biology, vol. 12, no. 5, pp. 308–319, 2011. View at Publisher · View at Google Scholar · View at PubMed
  3. S. M. Pupa, S. Ménard, S. Forti, and E. Tagliabue, “New insights into the role of extracellular matrix during tumor onset and progression,” Journal of Cellular Physiology, vol. 192, no. 3, pp. 259–267, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. D. Cox, M. Brennan, and N. Moran, “Integrins as therapeutic targets: lessons and opportunities,” Nature Reviews Drug Discovery, vol. 9, no. 10, pp. 804–820, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. N. Makrilia, A. Kollias, L. Manolopoulos, and K. Syrigos, “Cell adhesion molecules: role and clinical significance in cancer,” Cancer Investigation, vol. 27, no. 10, pp. 1023–1037, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. P. T. Caswell, S. Vadrevu, and J. C. Norman, “Integrins: masters and slaves of endocytic transport,” Nature Reviews Molecular Cell Biology, vol. 10, no. 12, pp. 843–853, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. B. H. Luo, C. V. Carman, and T. A. Springer, “Structural basis of integrin regulation and signaling,” Annual Review of Immunology, vol. 25, pp. 619–647, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. F. Ulrich and C. P. Heisenberg, “Trafficking and cell migration,” Traffic, vol. 10, no. 7, pp. 811–818, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. A. G. Ramsay, J. F. Marshall, and I. R. Hart, “Integrin trafficking and its role in cancer metastasis,” Cancer and Metastasis Reviews, vol. 26, no. 3-4, pp. 567–578, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. B. Felding-Habermann, T. E. O'Toole, J. W. Smith et al., “Integrin activation controls metastasis in human breast cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 4, pp. 1853–1858, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. R. C. Bates, D. I. Bellovin, C. Brown et al., “Transcriptional activation of integrin β6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma,” Journal of Clinical Investigation, vol. 115, no. 2, pp. 339–347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Mercurio, I. Rabinovitz, and L. M. Shaw, “The α6β4 integrin and epithelial cell migration,” Current Opinion in Cell Biology, vol. 13, no. 5, pp. 541–545, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. P. C. Brooks, S. Strömblad, L. C. Sanders et al., “Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3,” Cell, vol. 85, no. 5, pp. 683–693, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Nip, H. Shibata, D. J. Loskutoff, D. A. Cheresh, and P. Brodt, “Human melanoma cells derived from lymphatic metastases use integrin α(v)β3 to adhere to lymph node vitronectin,” Journal of Clinical Investigation, vol. 90, no. 4, pp. 1406–1413, 1992. View at Google Scholar · View at Scopus
  15. K. Friedrichs, P. Ruiz, F. Franke, I. Gille, H. J. Terpe, and B. A. Imhof, “High expression level of α6 integrin in human breast carcinoma is correlated with reduced survival,” Cancer Research, vol. 55, no. 4, pp. 901–906, 1995. View at Google Scholar · View at Scopus
  16. N. P. McCabe, S. De, A. Vasanji, J. Brainard, and T. V. Byzova, “Prostate cancer specific integrin αvβ3 modulates bone metastatic growth and tissue remodeling,” Oncogene, vol. 26, no. 42, pp. 6238–6243, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. M. Adachi, T. Taki, M. Higashiyama, N. Kohno, H. Inufusa, and M. Miyake, “Significance of integrin α5 gene expression as a prognostic factor in node-negative non-small cell lung cancer,” Clinical Cancer Research, vol. 6, no. 1, pp. 96–101, 2000. View at Google Scholar · View at Scopus
  18. J. S. Desgrosellier and D. A. Cheresh, “Integrins in cancer: biological implications and therapeutic opportunities,” Nature Reviews Cancer, vol. 10, no. 1, pp. 9–22, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. A. Kren, V. Baeriswyl, F. Lehembre et al., “Increased tumor cell dissemination and cellular senescence in the absence of β1-integrin function,” EMBO Journal, vol. 26, no. 12, pp. 2832–2842, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. N. E. Ramirez, Z. Zhang, A. Madamanchi et al., “The α2β1 integrin is a metastasis suppressor in mouse models and human cancer,” Journal of Clinical Investigation, vol. 121, no. 1, pp. 226–237, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. E. Matilla, T. Pellinen, J. Nevo, K. Vuoriluoto, A. Arjonen, and J. Ivaska, “Negative regulation of EGFR signalling through integrin-α1β1-mediated activation of protein tyrosine phosphatase TCPTP,” Nature Cell Biology, vol. 7, no. 1, pp. 78–85, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. T. Pellinen and J. Ivaska, “Integrin traffic,” Journal of Cell Science, vol. 119, no. 18, pp. 3723–3731, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. P. T. Caswell and J. C. Norman, “Integrin trafficking and the control of cell migration,” Traffic, vol. 7, no. 1, pp. 14–21, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. W. J. Chia and B. L. Tang, “Emerging roles for Rab family GTPases in human cancer,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1795, no. 2, pp. 110–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Stenmark, “Rab GTPases as coordinators of vesicle traffic,” Nature Reviews Molecular Cell Biology, vol. 10, no. 8, pp. 513–525, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. M. C. Jones, P. T. Caswell, and J. C. Norman, “Endocytic recycling pathways: emerging regulators of cell migration,” Current Opinion in Cell Biology, vol. 18, no. 5, pp. 549–557, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. S. Mitra, K. W. Cheng, and G. B. Mills, “Rab GTPases implicated in inherited and acquired disorders,” Seminars in Cell and Developmental Biology, vol. 22, no. 1, pp. 57–68, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. K. W. Cheng, J. P. Lahad, W. L. Kuo et al., “The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers,” Nature Medicine, vol. 10, no. 11, pp. 1251–1256, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. D. Subramani and S. K. Alahari, “Integrin-mediated function of Rab GTPases in cancer progression,” Molecular Cancer, vol. 9, article 312, 2010. View at Publisher · View at Google Scholar · View at PubMed
  30. Y. Mosesson, G. B. Mills, and Y. Yarden, “Derailed endocytosis: an emerging feature of cancer,” Nature Reviews Cancer, vol. 8, no. 11, pp. 835–850, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. A. Sorkin and M. von Zastrow, “Endocytosis and signalling: intertwining molecular networks,” Nature Reviews Molecular Cell Biology, vol. 10, no. 9, pp. 609–622, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. B. D. Grant and J. G. Donaldson, “Pathways and mechanisms of endocytic recycling,” Nature Reviews Molecular Cell Biology, vol. 10, no. 9, pp. 597–608, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. G. J. Doherty and H. T. McMahon, “Mechanisms of endocytosis,” Annual Review of Biochemistry, vol. 78, pp. 857–902, 2009. View at Publisher · View at Google Scholar · View at PubMed
  34. P. Caswell and J. Norman, “Endocytic transport of integrins during cell migration and invasion,” Trends in Cell Biology, vol. 18, no. 6, pp. 257–263, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. T. Pellinen, S. Tuomi, A. Arjonen et al., “Integrin trafficking regulated by Rab21 is necessary for cytokinesis,” Developmental Cell, vol. 15, no. 3, pp. 371–385, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. T. Pellinen, A. Arjonen, K. Vuoriluoto, K. Kallio, J. A. M. Fransen, and J. Ivaska, “Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of β1-integrins,” Journal of Cell Biology, vol. 173, no. 5, pp. 767–780, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. V. H. Lobert, A. Brech, N. M. Pedersen et al., “Ubiquitination of α5β1 integrin controls fibroblast migration through lysosomal degradation of fibronectin-integrin complexes,” Developmental Cell, vol. 19, no. 1, pp. 148–159, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. C. Gebhardt, U. Breitenbach, K. H. Richter et al., “c-Fos-dependent induction of the small ras-related GTPase Rab11a in skin carcinogenesis,” American Journal of Pathology, vol. 167, no. 1, pp. 243–253, 2005. View at Google Scholar · View at Scopus
  39. J. R. Goldenring, G. S. Ray, and J. R. Lee, “Rab11 in dysplasia of Barrett's epithelia,” Yale Journal of Biology and Medicine, vol. 72, no. 2-3, pp. 113–120, 1999. View at Google Scholar · View at Scopus
  40. W. Wang, S. Goswami, K. Lapidus et al., “Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors,” Cancer Research, vol. 64, no. 23, pp. 8585–8594, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. J. M. Cheng, L. Volk, D. K. M. Janaki, S. Vyakaranam, S. Ran, and K. A. Rao, “Tumor suppressor function of Rab25 in triple-negative breast cancer,” International Journal of Cancer, vol. 126, no. 12, pp. 2799–2812, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. J. R. Goldenring and K. T. Nam, “Rab25 as a tumour suppressor in colon carcinogenesis,” British Journal of Cancer, vol. 104, no. 1, pp. 33–36, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. K. T. Nam, H. J. Lee, J. J. Smith et al., “Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas,” Journal of Clinical Investigation, vol. 120, no. 3, pp. 840–849, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. P. T. Caswell, H. J. Spence, M. Parsons et al., “Rab25 associates with α5β1 integrin to promote invasive migration in 3D microenvironments,” Developmental Cell, vol. 13, no. 4, pp. 496–510, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. Y. H. Soung, J. L. Clifford, and J. Chung, “Crosstalk between integrin and receptor tyrosine kinase signaling in breast carcinoma progression,” BMB Reports, vol. 43, no. 5, pp. 311–318, 2010. View at Google Scholar · View at Scopus
  46. T. Nishimura and K. Kaibuchi, “Numb controls integrin endocytosis for directional cell migration with aPKC and PAR-3,” Developmental Cell, vol. 13, no. 1, pp. 15–28, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. L. Liu, B. He, W. M. Liu, D. Zhou, J. V. Cox, and X. A. Zhang, “Tetraspanin CD151 promotes cell migration by regulating integrin trafficking,” Journal of Biological Chemistry, vol. 282, no. 43, pp. 31631–31642, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. F. Shi and J. Sottile, “Caveolin-1-dependent β1 integrin endocytosis is a critical regulator of fibronectin turnover,” Journal of Cell Science, vol. 121, no. 14, pp. 2360–2371, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. M. Roberts, S. Barry, A. Woods, P. Van der Sluijs, and J. Norman, “PDGF-regulated rab4-dependent recycling of αvβ3 integrin from early endosomes is necessary for cell adhesion and spreading,” Current Biology, vol. 11, no. 18, pp. 1392–1402, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. M. S. Roberts, A. J. Woods, T. C. Dale, P. van der Sluijs, and J. C. Norman, “Protein kinase B/Akt acts via glycogen synthase kinase 3 to regulate recycling of αvβ3 and α5β1 integrins,” Molecular and Cellular Biology, vol. 24, no. 4, pp. 1505–1515, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. P. T. Caswell, M. Chan, A. J. Lindsay, M. W. McCaffrey, D. Boettiger, and J. C. Norman, “Rab-coupling protein coordinates recycling of α5β1 integrin and EGFR1 to promote cell migration in 3D microenvironments,” Journal of Cell Biology, vol. 183, no. 1, pp. 143–155, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. P. A. J. Muller, P. T. Caswell, B. Doyle et al., “Mutant p53 drives invasion by promoting integrin recycling,” Cell, vol. 139, no. 7, pp. 1327–1341, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. S. Hooper, C. Gaggioli, and E. Sahai, “A chemical biology screen reveals a role for Rab21-mediated control of actomyosin contractility in fibroblast-driven cancer invasion,” British Journal of Cancer, vol. 102, no. 2, pp. 392–402, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. W. Guo, Y. Pylayeva, A. Pepe et al., “β4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis,” Cell, vol. 126, no. 3, pp. 489–502, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. V. M. Weaver, S. Lelièvre, J. N. Lakins et al., “β4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium,” Cancer Cell, vol. 2, no. 3, pp. 205–216, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. A. M. Mercurio and I. Rabinovitz, “Towards a mechanistic understanding of tumor invasion—Lessons from the α6β4 integrin,” Seminars in Cancer Biology, vol. 11, no. 2, pp. 129–141, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. L. K. Diaz, M. Cristofanilli, X. Zhou et al., “β4 Integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer,” Modern Pathology, vol. 18, no. 9, pp. 1165–1175, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. S. O. Yoon, S. Shin, and A. M. Mercurio, “Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the α6β4 integrin,” Cancer Research, vol. 65, no. 7, pp. 2761–2769, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. P. G. Natali, C. V. Hamby, B. Felding-Habermann et al., “Clinical significance of α(v)β3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions,” Cancer Research, vol. 57, no. 8, pp. 1554–1560, 1997. View at Google Scholar · View at Scopus
  60. J. A. Nemeth, M. T. Nakada, M. Trikha et al., “Alpha-v integrins as therapeutic targets in oncology,” Cancer Investigation, vol. 25, no. 7, pp. 632–646, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. P. Koistinen, M. Ahonen, V. M. Kähäri, and J. Heino, “αV integrin promotes in vitro and in vivo survival of cells in metastatic melanoma,” International Journal of Cancer, vol. 112, no. 1, pp. 61–70, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. B. G. Gálvez, S. Matías-Román, M. Yáñez-Mó, M. Vicente-Manzanares, F. Sánchez-Madrid, and A. G. Arroyo, “Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells,” Molecular Biology of the Cell, vol. 15, no. 2, pp. 678–687, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. Z. Gu, E. H. Noss, V. W. Hsu, and M. B. Brenner, “Integrins traffic rapidly via circular dorsal ruffles and macropinocytosis during stimulated cell migration,” Journal of Cell Biology, vol. 193, no. 1, pp. 61–70, 2011. View at Publisher · View at Google Scholar · View at PubMed
  64. A. J. Woods, D. P. White, P. T. Caswell, and J. C. Norman, “PKD1/PKCμ promotes αvβ3 integrin recycling and delivery to nascent focal adhesions,” EMBO Journal, vol. 23, no. 13, pp. 2531–2543, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. M. C. Jones, P. T. Caswell, K. Moran-Jones et al., “VEGFR1 (Flt1) regulates Rab4 recycling to control fibronectin polymerization and endothelial vessel branching,” Traffic, vol. 10, no. 6, pp. 754–766, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. L. di Blasio, S. Droetto, J. Norman, F. Bussolino, and L. Primo, “Protein kinase D1 regulates VEGF-A-induced alphavbeta3 integrin trafficking and endothelial cell migration,” Traffic, vol. 11, no. 8, pp. 1107–1118, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. J. Vukmirica, P. Monzo, Y. Le Marchand-Brustel, and M. Cormont, “The Rab4A effector protein Rabip4 is involved in migration of NIH 3T3 fibroblasts,” Journal of Biological Chemistry, vol. 281, no. 47, pp. 36360–36368, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. Z. Fang, N. Takizawa, K. A. Wilson et al., “The membrane-associated protein, supervillin, accelerates F-actin-dependent rapid integrin recycling and cell motility,” Traffic, vol. 11, no. 6, pp. 782–799, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. D. P. White, P. T. Caswell, and J. C. Norman, “αvβ3 and α5β1 integrin recycling pathways dictate downstream Rho kinase signaling to regulate persistent cell migration,” Journal of Cell Biology, vol. 177, no. 3, pp. 515–525, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. A. Bandyopadhyay and S. Raghavan, “Defining the role of integrin αvβ6 in cancer,” Current Drug Targets, vol. 10, no. 7, pp. 645–652, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. A. G. Ramsay, M. D. Keppler, M. Jazayeri et al., “HS1-associated protein X-1 regulates carcinoma cell migration and invasion via clathrin-mediated endocytosis of integrin αvβ 6,” Cancer Research, vol. 67, no. 11, pp. 5275–5284, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus